Recognizing and reacting to recurrent pulmonary embolism.
D000284:Administration, Oral; D000925:Anticoagulants / Q000627:therapeutic use; D001791:Blood Platelet Disorders / Q000150:complications / Q000188:drug therapy; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007275:Injections, Intravenous; D010690:Phlebography; D011655:Pulmonary Embolism / Q000453:epidemiology / Q000209:etiology / Q000401:mortality / Q000517:prevention & control / Q000601:surgery / Q000628:therapy*; D012008:Recurrence; D013300:Streptokinase / Q000627:therapeutic use; D013442:Sulfinpyrazone / Q000627:therapeutic use; D013924:Thrombophlebitis / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy; D014682:Vena Cava, Inferior / Q000601:surgery
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006493:Heparin; D013300:Streptokinase; D013442:Sulfinpyrazone